About Hemostasis
Hemostasis is a company based in Saint Paul (United States) founded in 2006. It operates as a B2B. Hemostasis has completed 1 acquisition, including Fiagon. Hemostasis offers products and services including PosiSep® X, PosiSep® Hemostat, Accel®, NexStat®, and Vectra F ™. Hemostasis operates in a competitive market with competitors including Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Glycologix, among others.
- Headquarter Saint Paul, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Hemostasis, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hemostasis
Hemostasis offers a comprehensive portfolio of products and services, including PosiSep® X, PosiSep® Hemostat, Accel®, NexStat®, and Vectra F ™.
Hemostat for sinus procedures to control bleeding and aid healing.
Device for nasal bleeding control with tissue separation capabilities.
Powder to stop bleeding in surgical environments quickly and effectively.
Topical powder for external wound hemostasis and patient care.
Micro-sponge for targeted drug delivery in medical treatments.
Funding Insights of Hemostasis
Detailed funding history for Hemostasis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hemostasis
Hemostasis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fiagon.
Investment portfolio details for Hemostasis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical navigation systems for surgical applications to healthcare providers
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Hemostasis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Hemostasis
Detailed financials for Hemostasis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemostasis Comparisons
Peer comparison for Hemostasis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hemostasis
Hemostasis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Glycologix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hematology products and solutions are provided for medical applications.
|
|
| Locked | Locked | Locked |
Catheters for venous clot management and removal are developed.
|
|
| Locked | Locked | Locked |
Magnetic therapy is developed to treat blood-borne diseases.
|
|
| Locked | Locked | Locked |
Blood cleansing treatment device
|
|
| Locked | Locked | Locked |
Biopolymers are developed for soft tissue protection and repair.
|
Detailed competitors of Hemostasis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemostasis
Complete news archive for Hemostasis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemostasis
Hemostasis was founded in 2006.
Hemostasis is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Hemostasis, LLC is a medical technology company specializing in hemostatic products made from chitosan biopolymers. They design and produce devices like PosiSep for controlling bleeding in surgical and hospital settings, collaborating with physicians to enhance efficacy and patient outcomes. Based in Saint Paul, Minnesota, USA, the company serves global healthcare providers by innovating wound healing solutions and offering products for various medical applications.
Hemostasis's top competitors include Haemonetics, Glycologix and Vetex Medical.
Hemostasis offers PosiSep® X, PosiSep® Hemostat, Accel®, NexStat®, and Vectra F ™.
Hemostasis has made 1 acquisition, including Fiagon.